two significant new approaches for treating and preventing breast cancer
The FDA is close to approving two significant new approaches for treating and preventing breast cancer.
Herceptin (trastuzumab) will be a major breakthrough...it's the first monoclonal antibody for treating metastatic breast cancer.
It targets HER2...a protein that stimulates the growth of breast cancer cells. About 30% of women with breast cancer have tumors that produce excessive amounts of HER2.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote